ARMI will attend TERMIS-AM 2026, the premier North American conference for tissue engineering and regenerative medicine, bringing together researchers, clinicians, industry leaders, and innovators advancing the future of regenerative therapies.
ARMI will attend the Cell & Gene Meeting on the Mesa 2026, one of the industry’s leading conferences focused on overcoming the commercialization, manufacturing, and investment challenges facing advanced therapies
ARMI will attend the ISSCR 2026 Annual Meeting, the premier global gathering for stem cell research and regenerative medicine, to connect with scientific leaders and explore emerging advances shaping the future of the field.
ARMI Chief Operating Officer Jennifer MacDonald will participate in a panel discussion at the Cell & Gene Therapy Summit 2026, exploring the scientific, manufacturing, regulatory, and commercialization challenges involved in bringing advanced therapies to patients.
A webinar series from the Cato T. Laurencin Institute for Regenerative Engineering highlighting cutting-edge research and the mentorship dynamics shaping the next generation of scientists.
A webinar series from the Cato T. Laurencin Institute for Regenerative Engineering highlighting cutting-edge research and the mentorship dynamics shaping the next generation of scientists.
A webinar series from the Cato T. Laurencin Institute for Regenerative Engineering highlighting cutting-edge research and the mentorship dynamics shaping the next generation of scientists.
A webinar series from the Cato T. Laurencin Institute for Regenerative Engineering highlighting cutting-edge research and the mentorship dynamics shaping the next generation of scientists.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
